Free Trial

Omron (OMRNY) Expected to Announce Quarterly Earnings on Thursday

Omron logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Omron is scheduled to report quarterly results on Thursday, May 14, with analysts expecting $0.75 EPS and $1.5694 billion in revenue for the quarter.
  • In the prior quarter Omron posted $0.17 EPS, missing estimates, and analysts now forecast $1 EPS for the current fiscal year and $2 EPS for the next.
  • The stock trades around $37 with a market cap of $7.29 billion, a high P/E of 46.9 and low leverage (debt/equity 0.13); Zacks recently upgraded the rating to a Hold.
  • Five stocks we like better than Omron.

Omron (OTCMKTS:OMRNY - Get Free Report) is projected to post its resultson Thursday, May 14th. Analysts expect Omron to post earnings of $0.75 per share and revenue of $1.5694 billion for the quarter.

Omron (OTCMKTS:OMRNY - Get Free Report) last issued its quarterly earnings data on Thursday, February 5th. The company reported $0.17 EPS for the quarter, missing the consensus estimate of $0.36 by ($0.19). The business had revenue of $1.41 billion for the quarter, compared to analyst estimates of $1.38 billion. Omron had a return on equity of 2.46% and a net margin of 2.80%. On average, analysts expect Omron to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Omron Price Performance

Shares of OTCMKTS OMRNY opened at $37.05 on Thursday. The business has a 50-day moving average of $30.74 and a 200-day moving average of $28.14. The company has a debt-to-equity ratio of 0.13, a current ratio of 2.11 and a quick ratio of 1.37. The stock has a market capitalization of $7.29 billion, a price-to-earnings ratio of 46.90, a PEG ratio of 0.42 and a beta of 1.16. Omron has a fifty-two week low of $23.23 and a fifty-two week high of $37.73.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded shares of Omron from a "strong sell" rating to a "hold" rating in a research report on Monday, January 19th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat.com, Omron currently has an average rating of "Hold".

View Our Latest Stock Report on Omron

About Omron

(Get Free Report)

Omron Corporation OTCMKTS: OMRNY is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.

Featured Articles

Earnings History for Omron (OTCMKTS:OMRNY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Omron Right Now?

Before you consider Omron, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omron wasn't on the list.

While Omron currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't wait for the SpaceX IPO Cover

The space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines